These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22018178)

  • 1. Pharmacodynamics of glucocorticoids.
    Strehl C; Spies CM; Buttgereit F
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S13-8. PubMed ID: 22018178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
    Stahn C; Löwenberg M; Hommes DW; Buttgereit F
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of similarities and differences in glucocorticoid therapy between rheumatoid arthritis and ankylosing spondylitis - a systematic comparison.
    Spies CM; Burmester GR; Buttgereit F
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S152-8. PubMed ID: 19822064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids.
    Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids: The mode of action in bullous pemphigoid.
    Kubin ME; Hellberg L; Palatsi R
    Exp Dermatol; 2017 Dec; 26(12):1253-1260. PubMed ID: 28771827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.
    Buttgereit F; Saag KG; Cutolo M; da Silva JA; Bijlsma JW
    Scand J Rheumatol; 2005; 34(1):14-21. PubMed ID: 15903020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimised glucocorticoid therapy: the sharpening of an old spear.
    Buttgereit F; Burmester GR; Lipworth BJ
    Lancet; 2005 Feb 26-Mar 4; 365(9461):801-3. PubMed ID: 15733723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New glucocorticoids on the horizon: repress, don't activate!
    Song IH; Gold R; Straub RH; Burmester GR; Buttgereit F
    J Rheumatol; 2005 Jul; 32(7):1199-1207. PubMed ID: 16041872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel strategy of glucocorticoid drug development via targeting nongenomic mechanisms.
    Jiang CL; Liu L; Li Z; Buttgereit F
    Steroids; 2015 Oct; 102():27-31. PubMed ID: 26122209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects.
    van der Goes MC; Jacobs JW; Bijlsma JW
    Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S2. PubMed ID: 25608693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kaleidoscope of glucorticoid effects on immune system.
    Zen M; Canova M; Campana C; Bettio S; Nalotto L; Rampudda M; Ramonda R; Iaccarino L; Doria A
    Autoimmun Rev; 2011 Apr; 10(6):305-10. PubMed ID: 21224015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current insights into the development of new glucocorticoid receptor ligands].
    Buttgereit F; Song IH; Straub RH; Burmester GR
    Z Rheumatol; 2005 Apr; 64(3):170-6. PubMed ID: 15868334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genomic glucocorticoid effects to provide the basis for new drug developments.
    Song IH; Buttgereit F
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):142-6. PubMed ID: 16388891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and clinical relevance of nongenomic glucocorticoid actions.
    Buttgereit F
    Z Rheumatol; 2000; 59 Suppl 2():II/119-23. PubMed ID: 11155791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticosteroid action on the immune system: molecular and cellular aspects.
    Boumpas DT; Paliogianni F; Anastassiou ED; Balow JE
    Clin Exp Rheumatol; 1991; 9(4):413-23. PubMed ID: 1934694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
    Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids].
    Riccardi C
    Ann Ig; 2010; 22(1 Suppl 1):53-9. PubMed ID: 20701225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-genomic Effects of Glucocorticoids: An Updated View.
    Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O
    Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.